Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-TRI-WEEK: Atripla Dose Reduction in HIV-1
NCT01778413Phase 4Completed
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1). Started Jun 2013; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01778413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01778413.